Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Sweden Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20043
20054
20063
20071
20091
20101
20122
20134
20142
20151
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated4
Active, not recruiting1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Bristol-Myers Squibb6
Pfizer3
Ariad Pharmaceuticals2
Amsterdam UMC, location VUmc1
European LeukemiaNet1
Norwegian University of Science and Technology1
St. Olavs Hospital1
Takeda1
Uppsala University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive25
Leukemia6
Bone Marrow Diseases4
Leukemia, Myeloid4
Philadelphia Chromosome4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Hematologic Diseases3
Neoplasms by Histologic Type3
Bronchiolitis Obliterans Syndrome2
Leukemia, Myeloid, Chronic-Phase2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.